Report on mumps outbreak reflects vaccines' limited efficacy

04/9/2008 | WebMD · Reuters

Widespread use of two shots of the mumps vaccine manufactured by Merck & Co. did not prevent a U.S. outbreak of the disease in 2006. Of young adults who became ill, 84% had received the recommended two doses, CDC experts reported Wednesday. The findings suggest a better vaccine or changes in policy "may be needed to avert future outbreaks and achieve the elimination of mumps," the experts said.

View Full Article in:

WebMD · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID